Aarkstore Enterprise Laboratoire francais de Fractionnement et de Biotechnologies - Product Pipeline

Jan. 12, 2011 - PRLog -- Aarkstore announce a new report  "Laboratoire francais de Fractionnement et de Biotechnologies - Product Pipeline Review - Q4 2010" through its vast collection of market research report.

“Laboratoire francais de Fractionnement et de Biotechnologies - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together.

Scope

- Laboratoire francais de Fractionnement et de Biotechnologies - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Laboratoire francais de Fractionnement et de Biotechnologies human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Laboratoire francais de Fractionnement et de Biotechnologies with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Laboratoire francais de Fractionnement et de Biotechnologies’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Laboratoire francais de Fractionnement et de Biotechnologies’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Laboratoire francais de Fractionnement et de Biotechnologies in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Laboratoire francais de Fractionnement et de Biotechnologies’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Laboratoire francais de Fractionnement et de Biotechnologies.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Laboratoire francais de Fractionnement et de Biotechnologies and identify potential opportunities in those areas.

For more information, please visit:
http://www.aarkstore.com/reports/Laboratoire-francais-de-...
Or email us at press@aarkstore.com or call +919272852585

# # #

Aarkstore Enterprise specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers.